Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Hu3F8-BsAb |
Synonyms | |
Therapy Description |
Hu3F8-BsAb is a humanized bispecific antibody that targets CD3 and GD2, which may induce T-cell response against tumor cells expressing GD2 (PMID: 25542634). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Hu3F8-BsAb | hu3F8 x huOKT3 Bispecific Antibody | CD3 Antibody 99 | Hu3F8-BsAb is a humanized bispecific antibody that targets CD3 and GD2, which may induce T-cell response against tumor cells expressing GD2 (PMID: 25542634). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03860207 | Phase Ib/II | Hu3F8-BsAb | Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers | Terminated | USA | 0 |